Related Experiment Video
Updated: Jun 2, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
Published on: June 15, 2016
Characterization of a novel positive transcription regulatory element that differentially regulates the
Renzhong Li1, Liwei Ma, Yu Huang
1Research Center on Aging, Department of Biochemistry and Molecular Biology, Peking University Health Science Center, Beijing, People's Republic of China.
Abstract:
Alpha-2-macroglobulin (α2M), a protease inhibitor, is implicated in Alzheimer's disease, atherosclerosis, and other age-related diseases. The elevated level of α2M mRNA has been described in replicative senescence and it could be used as a biomarker of the aging cells. However, the mechanism responsible for the up-regulation of its expression is still unclear. This report identified a novel transcriptional regulatory element, the α2M transcription enhancement element (ATEE), within the α2M promoter. This element differentially activates α2M expression in senescent versus young fibroblasts. Electrophoretic mobility shift assays revealed abundant complexes in senescent cell nuclear extracts compared with young cell nuclear extracts. The DNase I footprint revealed the protein-binding core sequence through which the protein binds the ATEE. Mutation within ATEE selectively abolished α2M promoter activity in senescent (but not young) cells. These results indicated the ATEE, as a positive transcription regulatory element, contributes to the up-regulation of α2M during replicative senescence.
Insights
Researchers discovered a novel element in the Alpha-2-macroglobulin (α2M) gene promoter that increases its expression in aging cells. This finding sheds light on the mechanisms behind cellular senescence and potential biomarkers for age-related diseases.
Area of Science:
- Molecular Biology
- Cellular Aging
- Genetics
Background:
- Alpha-2-macroglobulin (α2M) is a protease inhibitor linked to age-related diseases like Alzheimer's.
- Elevated α2M mRNA levels are observed in senescent cells, suggesting its potential as a biomarker for cellular aging.
- The precise mechanisms driving α2M up-regulation during senescence remain largely unknown.
Purpose of the Study:
- To identify and characterize novel regulatory elements controlling α2M expression in senescent cells.
- To elucidate the molecular mechanisms underlying the increased α2M expression during replicative senescence.
Main Methods:
- Identification of a novel transcriptional regulatory element, the α2M transcription enhancement element (ATEE), within the α2M promoter.
- Electrophoretic mobility shift assays (EMSA) to detect protein-DNA interactions in senescent versus young fibroblasts.
- DNase I footprinting to pinpoint the protein-binding core sequence within the ATEE.
- Site-directed mutagenesis of the ATEE to assess its functional impact on α2M promoter activity.
Main Results:
- A novel transcriptional regulatory element, ATEE, was identified in the α2M promoter.
- ATEE demonstrated differential activation of α2M expression in senescent compared to young fibroblasts.
- EMSA revealed significantly higher protein-DNA complex formation with ATEE in senescent cell nuclear extracts.
- DNase I footprinting identified the specific protein-binding site within ATEE.
- Mutating the ATEE selectively abolished α2M promoter activity in senescent cells, but not in young cells.
Conclusions:
- The identified ATEE acts as a positive transcriptional regulatory element.
- ATEE plays a crucial role in the up-regulation of α2M expression during replicative senescence.
- This discovery provides insights into the molecular basis of cellular aging and identifies a potential target for therapeutic interventions in age-related diseases.
Related Concept Videos
Master Transcription Regulators
Master Transcription Regulators
General Transcription Factors
RNA Polymerase II Accessory Proteins
Regulation of Expression at Multiple Steps
Co-activators and Co-repressors

